MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma

被引:7
|
作者
Ji, L. [1 ,2 ]
Zhu, Z-N [2 ,3 ]
He, C-J [4 ]
Shen, X. [5 ]
机构
[1] Nanchang Univ, Affiliated Stomatol Hosp, Dept Gen Dent, Nanchang, Jiangxi, Peoples R China
[2] Key Lab Oral Biomed, Nanchang, Jiangxi, Peoples R China
[3] Nanchang Univ, Affiliated Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanchang, Jiangxi, Peoples R China
[4] Nanchang Univ, Fuzhou Med Coll, Fuzhou, Fujian, Peoples R China
[5] Nantong Univ, Dept Stomatol, Affiliated Hosp, Nantong, Peoples R China
关键词
miR-127-3p; Proliferation; Metastasis; Prognosis; KIF3B; Oral squamous cell carcinoma; TUMOR-SUPPRESSOR; DOWN-REGULATION; CANCER; PROLIFERATION; METASTASIS; STATISTICS; MIGRATION; INVASION; GROWTH; INJURY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: Recently, increased microRNAs have been shown to play an important role in the pathogenesis and progression of human cancers. including oral squamous cell carcinoma (OSCC). In this study, we focused on the function of microRNA-127-3p (miR-127-3p) associated with OSCC carcinogenesis. PATIENTS AND METHODS: MiR-127-3p and KIF3B expressions were observed via quantitative Real-time polymerase chain reaction (qRT-PCR) or Western blot in OSCC. The functions of mR-127-3p and KIF3B were investigated through MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) and transwell assays. And luciferase reporter assay was performed to confirm the relationship between mR-127-3p and KIF3B. RESULTS: First, down-regulation of miR-127-3p was identified in OSCC, which was associated with malignant clinicopathological features and poor prognosis in OSCC patients. Functionally, overexpression of miR-127-3p led to inhibition of cell proliferation and metastasis in OSCC. Further, KIF3B was confirmed to be a direct target of miR-127-3p. Moreover, upregulation of KIF3B was also observed in OSCC, which promoted tumorigenesis of OSCC. In particular, the upregulation of KIF3B partially attenuated the inhibitory effect of miR-127-3p on the development of OSCC. CONCLUSIONS: MiR-127-3p targeted KIF3B to inhibit the development of OSCC through suppressing cell proliferation, migration and invasion.
引用
收藏
页码:630 / 640
页数:11
相关论文
共 50 条
  • [21] mir-127-3p inhibits the proliferation of myocytes by targeting KMT5a
    Yuan, Renqiang
    Zhang, Xumeng
    Fang, Ying
    Nie, Yaping
    Cai, Shufang
    Chen, Yaosheng
    Mo, Delin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (02) : 970 - 976
  • [22] Possible role of miR-375-3p in oral squamous cell carcinoma progression
    Saika, Masato
    Nakashiro, Kohichi
    Tokuzen, Norihiko
    Shirai, Hiroyuki
    Uchida, Daisuke
    CANCER SCIENCE, 2025, 116 : 1166 - 1166
  • [23] LncRNA NEAT1 Targets miR-342-3p/CUL4B to Inhibit the Proliferation of Cutaneous Squamous Cell Carcinoma Cells
    Gong, Zhenhua
    Zhang, Yi
    Jiang, Yasu
    Chen, Peng
    Ji, Jianfeng
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [24] MiR-127-3p Inhibits Cell Growth and Invasiveness by Targeting ITGA6 in Human Osteosarcoma
    Wang, Dong
    Tang, Liang
    Wu, Huihui
    Wang, Kai
    Gu, Dongyun
    IUBMB LIFE, 2018, 70 (05) : 411 - 419
  • [25] Expression of miR-129-2 and miR-127-3p in glioma tissue and the clinical diagnostic value
    Xing, H. S.
    Liu, X. D.
    Zhang, L.
    Liu, H. Y.
    Du, X. L.
    Ma, Y. Q.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (01): : 25 - 32
  • [26] miR-127-3p在动脉粥硬化中的表达及干扰miR-127-3p对PDGF-BB处理的HAoSMC增殖迁移的影响
    缪丹丹
    张宁
    宋欢欢
    赵少华
    金玉
    柴建文
    中国循证心血管医学杂志, 2021, 13 (02) : 206 - 209
  • [27] Downregulated KIF3B Induced by miR-605-3p Inhibits the Progression of Colon Cancer via Inactivating Wnt/β-Catenin
    Wang, Qilong
    Hao, Xiaomin
    Xu, Gang
    Lv, Tiesheng
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [28] MiR-27a-3p targets USP46 to inhibit the cell proliferation of hepatocellular carcinoma
    Wen, Minghua
    Xu, Hongyan
    Peng, Hong
    Sheng, Yanling
    Yang, Wenlong
    Yan, Jinlong
    CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 100 (02) : 280 - 289
  • [29] A Comprehensive Evaluation of miR-144-3p Expression and Its Targets in Laryngeal Squamous Cell Carcinoma
    Mo, Bin-Yu
    Pang, Jin-Shu
    Dai, Wen-Bin
    Su, Ya-Si
    Jiang, Wei
    Huang, Su-Ning
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2021, 2021
  • [30] Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma
    Scholtz, Beata
    Horvath, Jozsef
    Tar, Ildiko
    Kiss, Csongor
    Marton, Ildiko J.
    PATHOGENS, 2022, 11 (02):